nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A “gut feeling” about precursor B-ALL
|
Roy, Anindita |
|
|
136 |
18 |
p. 1995-1996 |
artikel |
2 |
An intact gut microbiome protects genetically predisposed mice against leukemia
|
Vicente-Dueñas, Carolina |
|
|
136 |
18 |
p. 2003-2017 |
artikel |
3 |
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study
|
Tam, Constantine S. |
|
|
136 |
18 |
p. 2038-2050 |
artikel |
4 |
Chronic active Epstein-Barr virus infection
|
Abe, Nobuya |
|
|
136 |
18 |
p. 2090 |
artikel |
5 |
CXCL4's “Gliful” subversion of BM in MPN
|
Gurbuxani, Sandeep |
|
|
136 |
18 |
p. 1999-2000 |
artikel |
6 |
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
|
Yu, Jia |
|
|
136 |
18 |
p. 2080-2089 |
artikel |
7 |
Editorial Board
|
|
|
|
136 |
18 |
p. i |
artikel |
8 |
Hepatosplenic T-cell lymphoma: a rare but challenging entity
|
Pro, Barbara |
|
|
136 |
18 |
p. 2018-2026 |
artikel |
9 |
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN
|
Gleitz, Hélène F.E. |
|
|
136 |
18 |
p. 2051-2064 |
artikel |
10 |
Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance
|
Pinney, Jonathan J. |
|
|
136 |
18 |
p. 2065-2079 |
artikel |
11 |
Targeting complement activation in COVID-19
|
Kulkarni, Hrishikesh S. |
|
|
136 |
18 |
p. 2000-2001 |
artikel |
12 |
The race to stymie BTK: zanu zings
|
Kapoor, Prashant |
|
|
136 |
18 |
p. 1997-1999 |
artikel |
13 |
Unexpected and prominent parvovirus infection in a patient with plasma cell myeloma
|
Singh, Amrit P. |
|
|
136 |
18 |
p. 2091 |
artikel |
14 |
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up
|
Trotman, Judith |
|
|
136 |
18 |
p. 2027-2037 |
artikel |